News

The DZHK supports women in research during the particularly challenging phase of life when they are caring for children and at the same time laying the foundation for their academic careers. One of them is biologist Daniela Panáková from the Max Delbrück Center for Molecular...

Greifswald is getting a new research building for community medicine, where researchers want to find out more about dementia, cardiovascular diseases, and cancer connected with demographic change. The DZHK site in Greifswald will also move into the future new building.

Dr. Wesley Abplanalp is an American physiologist and basic scientist working on cardiovascular inflammation and regeneration. He is part of the research group of DZHK board member Prof. Stefanie Dimmeler at the Institute of Cardiovascular Regeneration at the Goethe-University...

How can older patients suffering from multiple chronic diseases be better cared for? A clinical trial is testing a new treatment approach in patients with chronic heart failure, psychological distress, and at least two other concomitant physical illnesses. Especially when mental...

The inner surface of blood vessels is lined by a wafer-thin layer of cells known as the endothelium, which forms a crucial barrier between blood and the surrounding tissue. The single-layered cell structure promotes the exchange of oxygen and nutrients, while simultaneously...

Revacept is a novel platelet inhibitor that binds specifically to injured blood vessels and can be used safely during catheter interventions. This is now demonstrated in a study enrolling patients with narrowed coronary arteries co-funded by the German Centre for Cardiovascular...

Those who need to change their eating habits to normalise their blood pressure should start with a fast. A research group led by DZHK scientists Dr Sofia Forslund and Prof. Dominik N. Müller has investigated why patients can use it as a tool to improve their health in the long...

Recovering from a corona infection at home - that's what most people want to do. But sometimes hospitalization is unavoidable. But when is the right time for this? This is being investigated by the COVID SMART study at LMU Klinikum München. Anyone who has risk factors for a...

In the newly inaugurated Käthe-Beutler-Haus, research teams in vascular biomedicine from the Berlin Institute of Health (BIH) at Charité and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) will work under one roof in the future. The MDC is a...

A team of researchers led by Prof. Wolfram Ruf, Principal Investigator at the DZHK and Scientific Director of the Center for Thrombosis and Hemostasis (CTH) at the University Medical Center Mainz, has uncovered the mechanism that triggers the autoimmune disease APS...